MedTrace Logo

Heart TIMING - Heart Transplantation IMagING

NCT03499197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-04-17

No results posted yet for this study

Summary

The cardiac allograft rejection (CAR) and cardiac allograft vasculopathy (CAV) significantly affect the prognosis of patients after heart transplantation. The aim of the present study is to investigate and differentiate the adaptive and pathological cardiovascular changes after heart transplantation using different modalities. The investigator's main purpose is to define the role of the cardiovascular imaging methods and biomarkers in the early diagnosis of CAR and CAV.

Conditions

  • Heart Transplant Failure and Rejection
  • Magnetic Resonance Imaging

Interventions

DIAGNOSTIC_TEST

cardiac magnetic resonance imaging

Detailed and regular CMR examination (LGE, stress perfusion, T1, T2 mapping)

Sponsors & Collaborators

  • National Research, Development and Innovation Fund of Hungary, Project no. NVKP_16-1-2016-0017

    collaborator UNKNOWN

  • Semmelweis University Heart and Vascular Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2021-01-15
Completion
2026-01-15

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499197 on ClinicalTrials.gov